SurvivorNet on MSN
New lung cancer drug, Ivonescimab, showed promising results in major HARMONi-6 trial, but US patients will need to wait for HARMONi-3 update
A new drug called ivonescimab just beat standard immunotherapy in a major lung cancer trial: patients lived nearly four ...
About half of people diagnosed with metastatic non-small-cell lung cancer never receive treatment, despite advances in ...
Clinical trial finds 55 per cent of patients on lorlatinib experience no disease progression for at least seven years A Hong ...
Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...
A new drug has shown major promise on its ability to suppress advanced lung cancer into a manageable chronic disease, ...
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung ...
Although cancer treatments are improving fast, prevention has so far been mostly about promoting a healthy lifestyle. But ...
Presentations at the 51st ONS Congress explained how oncology nurses can help patients navigate the often-bewildering terrain ...
Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...
Lung cancer poses a potential smoke screen for today’s pulmonologists. Overall, incidence rates continue to decline in the US as other cancers are on the rise, yet a growing number of patients are ...
More than four million patients have already received a faster lung cancer diagnosis or all-clear thanks to AI, the ...
Cabrini Hospital marks a major milestone with its Ion Robotic Navigational Bronchoscopy System, treating 100 patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results